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Supplementary Figures 
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Supplementary Figure 1 ARHGAP33 mRNA localization.  
(a, b) Fluorescent in situ hybridization for ARHGAP33 mRNA in a sagittal section of adult WT mice (a) and 
ARHGAP33 KO mice (a, inset). Higher magnification of the hippocampus is shown in b. Cb, cerebellum; CP, 
caudate-putamen; CX, cerebral cortex; Hi, hippocampus; MB, midbrain; MO, medulla oblongata; OB, 
olfactory bulb; Th, thalamus. CA, cornu ammonis; DG, dentate gyrus; Gr, granule cell layer; Or, oriens layer; 
Py, pyramidal cell layer; Ra, radiatum layer. Scale bars, 1 mm (a), 500 μm (b). (c-f) Fluorescent in situ 
hybridization for ARHGAP33 mRNA together with VGLUT1 mRNA (c) and GAD67 mRNA (e) in the 
dentate gyrus of the hippocampus. Gr, granule cell layer; ML, molecular layer; Pl, polymorphic layer. Scale 
bars, 20 μm. (g-j) Fluorescent in situ hybridization for ARHGAP33 mRNA together with VGLUT1 mRNA 
(g) and GAD67 mRNA (i) in the CA1 region of the hippocampus. LM, stratum lacunosum-moleculare; Or, 
Stratum oriens; Py, pyramidal cell layer; Ra, stratum radiatum. Scale bars, 20 μm. Note that ARHGAP33 
mRNA was colocalized both with VGLUT1 mRNA and GAD67 mRNA (arrow head) in the dentate gyrus and 
the CA1 region of the hippcampus (c, e, g, i). 
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Supplementary Figure 2 
Supplementary Figure 2 Generation of ARHGAP33 KO mice.  
(a) Schematic representation of the wild-type allele, targeting vector, and the targeted ARHGAP33 allele. 
Neo, neomycin-resistant gene; PGK, phoshoglycerate kinase promoter; TK, thymidine kinase gene. (b) 
Immunoblotting for ARHGAP33 in adult wild-type and ARHGAP33 KO mouse brain lysates. Tubulin was 
used as a loading control. (c) Normal body size of ARHGAP33 KO mice compared to WT mice (WT, N = 14; 
ARHGAP33 KO, N = 14; P > 0.05, Mann-Whitney U-test). Bars show median values. (d) Nissl staining in 
coronal brain sections including hippocampus of adult WT and ARHGAP33 KO mice. Higher magnifications 
of the hippocampus are shown in the right panels. Scale bars, 1 mm. 
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Supplementary Figure 3 
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Supplementary Figure 3 Normal behavior of ARHGAP33 KO mice.  
(a) The rotarod test. The average of time spent on the rotarod across 8 test trials for WT (open circles) and 
ARHGAP33 KO (closed circles) mice (WT, N = 12, ARHGAP33 KO, N = 11). There were no significant 
differences between the two genotypes (P > 0.05, repeated-measures ANOVA). The data are expressed as 
mean ± s.e.m. (b) The open field test. Normal locomotor activity in ARHGAP33 KO mice (closed circles) in 
the open field test compared to WT mice (open circles) (WT, N = 14, ARHGAP33 KO, N = 14). There were 
no significant differences between the two genotypes (P > 0.05, Two-way ANOVA with repeated measures). 
The data are expressed as mean ± s.e.m. (c, d) The contextual fear conditioning test. Freezing responses on 
the conditioning day (c). 170 s after the placement of mice in the conditioning chamber, a tone was presented 
for 10 s (solid line); at the end of the tone, mice were given a footshock for 2 s (arrow). Freezing responses 
in the contextual fear conditioning test (WT, N = 14, ARHGAP33 KO, N = 12, P > 0.05, Two-way ANOVA 
with repeated measures) (d). There were no significant differences between the two genotypes (P > 0.05, 
Two-way ANOVA with repeated measures). The data are expressed as mean ± s.e.m. (e, f) The Morris water 
maze test. The escape latency in the training session (WT, N = 14, ARHGAP33 KO, N = 12, P > 0.05, 
Two-way ANOVA with repeated measures) (e). The time spent in each quadrant during the probe trials (WT, 
N = 14, ARHGAP33 KO, N = 12, P > 0.05, Mann-Whitney U-test) (f). Bars show median values. (g) The 
elevated plus-maze test. The time spent on open arms (WT, N = 14, ARHGAP33 KO, N = 12, P > 0.05, 
one-way ANOVA) (left). Entries into open arms (WT, N = 14, ARHGAP33 KO, N = 12, P > 0.05, one-way 
ANOVA) (right). Bars show mean values. (h) Responses to acoustic stimuli. Mean amplitudes of startle 
responses in WT (open circles) and ARHGAP33 KO (closed circles) mice (WT, N = 12, ARHGAP33 KO, N = 
11) are shown. There were no significant differences between the two genotypes (P > 0.05, Two-way 
ANOVA with repeated measures). The data are expressed as mean ± s.e.m. N.S., not significant. 
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Supplementary Figure 4 
 
 
Supplementary Figure 4 Effects of SORT1 knockdown with shRNA construct 
(TRCN0000034494). 
(a) Weakened interaction between ARHGAP33 and TrkB in the SORT1 knockdown neuron. ARHGAP33 
immunoprecipitates and total lysates were immunoblotted with the indicated antibodies. Representative blots 
(left), quantification of co-immunoprecipitated TrkB (center), and quantification of SORT1 expression (right) 
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(each N = 7; TrkB, P = 0.0017, SORT1, P = 0.0017, Mann-Whitney U-test). The averaged values of the 
control neurons were set to 100%. Bars show median values. Western blots show representative results from 
7 independent experiments performed using neurons from different mice. cont., control. KD, knockdown. 
Note that another shRNA construct (TRCN0000034494) targeted to region of SORT1 that does not overlap 
with that targeted by the shRNA used in Fig. 7c was used. (b) Requirement of SORT1 in 
ARHGAP33-mediated TrkB trafficking. Biotinylated cell surface proteins and total lysates were 
immunoblotted with the indicated antibodies. Representative blots (left) and quantification of surface TrkB 
expression (right) (each N = 10; WT vs ARHGAP33 KO in the control neurons, corrected P = 6.2×10-4; WT 
vs ARHGAP33 KO in the SORT1 knockdown neurons, corrected P > 0.05, Mann-Whitney U-test with the 
Ryan’s correction). The averaged values of the control neurons from WT mice were set to 100%. Western 
blots show representative results from 10 independent experiments performed using neurons from different 
mice. cont., control. KD, knockdown. Bars show median values. Note that another shRNA construct 
(TRCN0000034494) targeted to region of SORT1 that does not overlap with that targeted by the shRNA used 
in Fig. 7c was used. 
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Supplementary Figure 5  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 5 Original uncropped images of western blots.  
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Supplementary Figure 5 (continued) 
 
 
 
Supplementary Figure 5 (continued) Original uncropped images of western blots.  
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Supplementary tables 
 
 
 
 
 
Supplementary Table 1. Demographic information for patients with schizophrenia  
and healthy controls included in expression analysis 
Variables Schizophrenia (N = 45) Control (N = 45) 
Age (years) 32.3 ± 10.7 32.3 ± 12.7 
Sex (male/female) 29/16 29/16 
CPZ-eq (mg/day) 737.7 ± 587.1 - 
Age at onset (years) 22.2 ± 8.5 - 
Duration of illness (years) 9.9 ± 7.8 - 
PANSS Positive Symptoms 24.0 ± 7.3 - 
PANSS Negative Symptoms 25.8 ± 8.6 - 
PANSS General Psychopathology 54.3 ± 14.1 - 
PANSS, Positive and Negative Syndrome Scale;  
CPZ-eq, chlorpromazine equivalent of total antipsychotics. Mean ± s.d. 
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Supplementary Table 2. Demographic information for patients with schizophrenia  
and healthy controls included in brain structure analysis 
Variables Schizophrenia (N = 124) Control (N = 407) P values (z) 
Age (years) 37.5 ± 12.3 35.4 ± 12.5 0.055 (1.9) 
Sex (male/female) 70/54 191/216 0.063 (3.4)a 
Education (years) 14.1 ± 2.3 15.0 ± 2.2 <0.001 (-3.2) 
Estimated premorbid IQ 101.9 ± 10.1 107.6 ± 8.1 <0.001 (-5.6) 
Handedness (Rt./Lt./Bil.) 120/4/0 383/23/1 0.48 (1.5)a 
CPZ-eq (mg/day) 572.8 ± 536.4 - - 
Age at onset (years) 24.9 ± 10.2 - - 
Duration of illness (years) 12.5 ± 9.8 - - 
PANSS Positive Symptoms 18.5 ± 5.7 - - 
PANSS Negative Symptoms 19.3 ± 6.2 - - 
PANSS General Psychopathology 40.6 ± 11.1 - - 
PANSS, Positive and Negative Syndrome Scale; CPZ-eq, chlorpromazine equivalent of total 
antipsychotics. Mean ± s.d. and p values are shown. Significant P values are shown as bold face 
and underlined. aχ2 test. Complete demographic information was not obtained for all subjects 
(estimated premorbid IQ and PANSS in patients: N = 115 and N = 122; estimated premorbid IQ in 
controls: N = 406). 
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Supplementary Table 3. Effects of ARHGAP33 genotype-diagnosis interaction on brain  
structure in total subjects 
      
Talairach coordinates 
Brain regions R/L BA CS T corrected p value x y z 
ARHGAP33 genotype-diagnosis interaction 
     
Middle Temporal Gyrus L 21 286 4.39 7.2×10-4 -49 6 -35 
Medial Frontal Gyrus R 25 555 4.26 1.1×10-3 5 16 -13 
Inferior Temporal Gyrus R 20 451 3.69 8.5×10-3 57 -12 -20 
R, right; L, left; BA, Brodmann area; CS,Cluster size; T, Peak-voxel T. 
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Supplementary Methods 
 
Nucleotide sequence of the cRNA probe of ARHGAP33 for in situ hybridization 
 
5’- 
ATGCTCCAGA CACAGAGAGA GTCAGATCCC ATCCTGCCTT GGGGAGCTTC ATGGGCTGGC AGGGGACAGA CCCTGAGGGC CCGAAGCACT 
GACAGCCTGG ATGGCCCAGG GGAGGGCTCA GTGCAGCCTG TTCCCTCTAC TGGAGGGCCC AGTGTGAAGG GGAAGCCTGG GAAGAGGCTC 
TCAGCTCCTC GAGGTCCCTT TCCTCGGCTG GCCGACTGTG CCCATTTCCA CTATGAGAAT GTTGACTTTG GCCATATTCA GCTCCTACTG 
TCTCCAGAGC GTGAAGGCCC CAGCCTCTCT GGAGAGAATG AGCTGGTATT TGGGGTGCAG GTAACCTGTC AGGGCCGTTC TTGGCCAGTT 
CTTCGTAGTT ACGATGACTT CCGTTCCCTG GATGCCCACC TGCACCGATG CATATTTGAC CGGAGGTTTT CCTGCCTTCC AGAGCTCCCT 
CCACCCCCAG AGGGTGCTAG GGCTGCCCAG ATGCTGGTAC CTCTGCTGCT GCAGTATCTG GAGACCCTGT CTGGACTGGT GGACAGTAAC 
CTCAACTGTG GGCCTGTGCT CACTTGGATG GAGCTGGACA ATCATGGCCG ACGATTGCTC CTCAGTGAGG AGGCCTCCCT CAATATCCCT 
GCAGTGGCTG CCGCTCATGT GGTCAAACGG TACACAGCTC AGGCACCAGA TGAGCTCTCC TTTGAGGTGG GAGACATCGT CTCAGTGATC 
GACATGCCAC CCACAGAGGA TCGGAGCTGG TGGCGGGGCA AGCGGGGCTT CCAGGTTGGT TTCTTCCCCA GCGAGTGTGT AGAACTCTTC 
ACAGAGAGGC CAGGTCCTGG CTTAAAGGCA GATGCTGATG GTTCCCTGTG TGGCATCCCA GCTCCCCAGG GTAACTCTTC TCTCACCTCA 
GCTGTGCCCC GGCCACGTGG GAAGCTGGCT GGCCTCCTCC GAACCTTCAT GCGCTCCCGC CCTTCTCGGC AGCGGTTGCG GCAGCGGGGA 
ATTCTGCGGC AGAGAGTATT TGGCTGTGAC CTTGGAGAGC ATCTCAGCAA CTCAGGCCAG GATGTGCCCC AAGTGCTGCG CTGCTGCTCT 
GAGTTTATTG AGGCCCATGG GGTGGTGGAT GGAATCTACC GGCTCTCAGG CGTGTCCTCC AACATCCAGA GGCTACGGCA TGAATTTGAC 
AGTGAGAGGA TTCCTGAACT ATCTGGCCCT GCCTTCCTGC AGGACATCCA CAGTGTATCC TCCCTTTGCA AACTCTACTT CCGAGAGCTA 
CCAAACCCCC TACTCACCTA CCAGCTCTAT GGGAAATTCA GTGAGGCCAT GTCAGTCCTA GGGGAGGAAG AACGCCTGGT GAGAGTCCAT 
GATGTCATCC AGCAGTTGCC CCCACCACAC TACAGGACTC TAGAGTACCT GCTGAGGCAC TTGGCCCGCA TGGCAAGACA TAGTGCCAAT 
ACCAGCATGC ATGCCCGCAA CTTGGCCATT GTCTGGGCAC CCAACCTGCT CCGGTCCATG GAGCTAGAGT CAGTGGGGCT GGGTGGGGCG 
GCAGCCTTCC GGGAGGTTCG TGTGCAGTCA GTGGTGGTGG AATTCCTGCT CACCCATGTG GAGGTCCTGT TTAGTGACAC CTTCACCTCT 
GCTGGCCTAG ACCCTGCAGG CCGCTGTCTT CTCCCCAGGC CCAAGTCCCT TGCGGGAAGT GGCCCCTCTA CTCGCCTGCT GACACTGGAA 
GAAGCCCAGG CTCGTACCCA GGGCCGGCTG GGAACACCCA CTGAGCCCAC AACTCTCAAG GCTGCAGCCT CACCTGTGGA AAAGAGGAAA 
AGGGAGAGAG GGGAAAAACA GCGGAAGCCA GGGGGCAGCA GCTGGAAGAC ATTCTTTGCT CTTGGCCGGG GCCCCAGCAT CCCCCGGAAG 
AAGCCTCTAC CCTGGCTGGG GGGCTCTCGT GCACCACCAC AGCCTTCAGG CAACCGACCT GACACAGTCA CACTGAGGTC GGCTAAGAGT 
GAAGAGTCTC TATCATCACA GGCCAGTGGG ACTGGCCTCC AGAGGCTACA CAGGCTACGG CGACCCCACT CCAGCAGCGA TGCTTTCCCA 
GTGGGCCCAG CACCTGCTGG CTCCTGCGAG ACCCTGTCTT CTTCTTCTTC TTCTTCCTCC TCCTCGTCAG CCTCCTCCTC ATCATCATCA 
TCTGAGTCCT CAGCAGCTGG GCTGGGGCCA CTTTCCGGGT CACCCTCACA TCGCACCTCA GCCTGGCTAG ATGATGGTGA TGAACTGGAC 
TTTAGCCCAC CCCGCTGCCT GGAGGGACTC CGGGGCCTGG ACTTTGATCC GCTTACCTTT CGCTGCAGCA GCCCCACCCC AGGGGACCCT 
GCACCTCCTG CCAGCCCAGC ACCCCCAGCA CCCGCCTCTG CCTGCCCACC CAGGGCAACC CCCAAGGCTC CCTCACCCCG AGGACCCACC 
AGCCCAGCTT CGTCCACTGC TCTGGACATC TCAGAGCCCC TGGCTGTGTC TGTACCACCT GCTGTCCTAG AACTGCTGGG GGCAGGAGGA 
ACACCTGCCT CGGTCACCCC AACACCAGCT CTCAGCCCTG GCCCAGGCTT GCGCCCCCAT CTCATCCCCT TGCTGCTGCA TGGATCAGAG 
GCCCAGCTAA GTGACACCTG CCAACAAGAG ATCAGCAGTA AGCTGGCACT GCCTGGTCCT GGGGGAAGCC AAGGTCCTGG TATAGATTCA 
CCATTGCTGC CCCCACCTCT GTCCCTTCTA CGCCCTGGTG GGGCCCCACC CCCACCCCCC AAGAACGCAG CGCGCCTCAT GGCACTGGCC 
CTGGCTGAGC GGGCTCAGCA GGTGGCTAAG CAACAGAGCC AGCAGGAGCA TGCAAGCACC TCAACTAGTC CACACTCCCC TTTCCGCCGT 
TCACTGTCCC TGGAGGTCGG TGGGGAACCT GTGGTAACTT CAGGGAGTGG ACCACCCCCT CACTCCCTAG CCCACCCTGG TGTCTGGGCC 
CCAGGACCCC CACCCTACCT ACCAAGGCAA CAAAGTGATG GGAGCCTGGT ACGGAGCCAG CGGCCTGTGG GGACCTCAAG GAGGGGTCTC 
AGAGGCCCTG CTCAGGTTCC TACCCCTAGT GTCTTTTCTC CAGCTCCCCG GGAGTGCCTG CCACCTTTCC TTGGGGTCTC CAAACCAGGC 
TTGTACCCTC TCGCCCCCTC CTCCTTTCAA CCCAACTCCT CAGCCCAAGT CTGGAGGAAT TCTCTGGGCC CCCCTGCACC TCTTGACAGG 
GGAGAGAACC TGTACTATGA GATTGGGGCT AGTGAGGGTT CCCCCTATTC TGGGCCCACT CGGTCCTGGA GTCCTTTTCG CTCCATGCCC 
CCTGATAGGC TCAGTGCCTC ATATGGCATG CTTGGCCAGT CACCACCACT TCACAGGTCA CCTGACTTCC TGCTCAGCTA CCCACCGCCC 
CCCTCCTGCT TTCCACCTGA CCACCTTGGC TATTCGGTCC CCCAGCACCC TGCCCGGCAC CCTACCCGGC CAGAGCCCCT CTATGTCAAC 
CTAGCCCTAG GGCCCAGGGG TCCTTCACCT GCCTCTTCCT GCTCCTCTTC CCCTCCTGCC CATCCCAGAA GTCGTTCGGA TCCTGGGCCC 
CCAGCACCTC GTCTCCCTCA GAAGCAGCGG GCTCCCTGGG GCTCCAATAC CCCTCATAGG GTAACAGGAC CTTGGGGCCC TCCTGAACCT 
CTCCTGCTCT ACAGGGGATC CCCACCAGCC TATGGGAGGG GGAGCGAGCA TTACCAAGGG TCTTTGTACA GAAATGGGGG TCAGAGGGGA 
GAGGGGGCTG GTCCTCCACC  TCCTTACCTC ACTCCCAGTT  GGTCCCTCCA CTCTGAGGGC CAGACCCGAA  GCTACTGTTG A-3’ 
